Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial
暂无分享,去创建一个
E. Song | Bing-he Xu | Wentao Yang | Z. Shao | D. Pang | C. Geng | Tao Huang | Lili Tang | Hongjian Yang | Y. Lei | S. Cui | Sheng Chen | Yongsheng Wang | H. Zheng | Jin Zhang | Liang Huang | T. Huang | Hong Zheng